Literature DB >> 184909

Primary hyperlipoproteinemia in childhood and adolescence: identification and treatment of persons at risk for premature atherosclerosis.

V Rose, D M Allen, R G Pearse, J Chapell.   

Abstract

Determination of serum cholesterol values in three populations of children and adolescents, totalling 4013 subjects aged 1 month to 20 years, revealed 16 cases of primary hyperbetalipoproteinemia (overall frequency, 1:251) and led to the detection of the disorder in 12 asymptomatic siblings. The upper limit of normal for serum cholesterol concentration was approximately 200 mg/dl at all ages studied. Dietary treatment was instituted in patients whose serum cholesterol value exceeded this limit and in whom a primary lipid defect was confirmed; the serum cholesterol value decreased in all patients who adhered to the diet. However, since the potential hazards and long-term results of dietary treatment, with or without drug therapy, in growing children are not known, such treatment should be reserved for affected children with a family history of premature atherosclerosis, and follow-up is essential.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184909      PMCID: PMC1878808     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  18 in total

Review 1.  Hyperlipidaemia in children.

Authors:  J K Lloyd
Journal:  Br Heart J       Date:  1975-02

Review 2.  Atherosclerosis as a pediatric problem.

Authors:  W B Kannel; T R Dawber
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

3.  Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.

Authors:  C J Glueck; R Fallat; R Tsang
Journal:  Pediatrics       Date:  1973-11       Impact factor: 7.124

Review 4.  The inheritance of familial hypercholesterolemia.

Authors:  J Jensen; D H Blankenhorn
Journal:  Am J Med       Date:  1972-04       Impact factor: 4.965

Review 5.  The morphogenesis and fate of potential and early atherosclerotic lesions in man.

Authors:  M D Haust
Journal:  Hum Pathol       Date:  1971-03       Impact factor: 3.466

6.  Use of cholestyramine in treatment of children with familial hypercholesterolaemia.

Authors:  R J West; J K Lloyd
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

7.  Atherosclerosis, cholesterol, and the pediatrician.

Authors:  A Drash
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

Review 8.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-26       Impact factor: 91.245

9.  Primary disorders of the serum lipoproteins in childhood.

Authors:  O H Wolff
Journal:  Pediatrics       Date:  1967-07       Impact factor: 7.124

10.  Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.

Authors:  P O Kwiterovich; D S Fredrickson; R I Levy
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  2 in total

1.  Hypercholesterolaemia treated by soybean protein diet.

Authors:  A Gaddi; G C Descovich; G Noseda; C Fragiacomo; A Nicolini; G Montanari; G Vanetti; M Sirtori; E Gatti; C R Sirtori
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

Review 2.  Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.

Authors:  Anita Malhotra; Nusrat Shafiq; Anjuman Arora; Meenu Singh; Rajendra Kumar; Samir Malhotra
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.